Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents | Zendy

Adnan Kastrati | Zendy; Alban Dibra | Zendy; Julinda Mehilli | Zendy; Sandra Mara Mayer | Zendy; Susanne Pinieck | Zendy; Jürgen Pache | Zendy; Josef Dirschinger | Zendy; Albert Schömig | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents

Author(s) -

Adnan Kastrati,

Alban Dibra,

Julinda Mehilli,

Sandra Mara Mayer,

Susanne Pinieck,

Jürgen Pache,

Josef Dirschinger,

Albert Schömig

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.601823

Subject(s) - medicine , restenosis , stent , sirolimus , lesion , stenosis , cardiology , odds ratio , revascularization , drug eluting stent , target lesion , paclitaxel , percutaneous coronary intervention , radiology , surgery , myocardial infarction , cancer

The efficacy of drug-eluting stents in reducing restenosis risk has not been uniform across patient subsets. Identifying predictive factors of restenosis may help improve outcomes after percutaneous coronary interventions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research